Scenario: VU could garner up to $422MM, as fight against neurospsych disorders, degenerative diseases advances.
[Updated] Less than three years into their mission, Deerfield, Mountain Group and founders press forward.
The word is just getting out about new entrant in Tennessee biopharm ecosystem.
Lynch cites workforce challenges and the need for more collaboration throughout the region as essential to lift Nashville from lower tier of life-science centers
Vanderbilt pharma program inches cautiously toward tech transfer, while key faculty member keeps firm hand on the tiller
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: